Literature DB >> 7494814

Pharmaceutical solids: a strategic approach to regulatory considerations.

S Byrn1, R Pfeiffer, M Ganey, C Hoiberg, G Poochikian.   

Abstract

PURPOSE: This review describes a conceptual approach to the characterization of pharmaceutical solids.
METHODS: Four flow charts are presented: (1) polymorphs, (2) hydrates, (3) desolvated solvates, and (4) amorphous forms.
RESULTS: These flow charts (decision trees) are suggested as tools to develop information on pharmaceutical solids for both scientific and regulatory purposes.
CONCLUSIONS: It is hoped that this review will lead to a more direct approach to the characterization of pharmaceutical solids and ultimately to faster approval of regulatory documents containing information on pharmaceutical solids.

Mesh:

Substances:

Year:  1995        PMID: 7494814     DOI: 10.1023/a:1016241927429

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  12 in total

1.  DISSOLUTION BEHAVIOR OF CRYSTALLINE SOLVATED AND NONSOLVATED FORMS OF SOME PHARMACEUTICALS.

Authors:  E SHEFTER; T HIGUCHI
Journal:  J Pharm Sci       Date:  1963-08       Impact factor: 3.534

2.  Polymorphism and drug availability. Solubility relationships in the methylprednisolone system.

Authors:  W I HIGUCHI; P K LAU; T HIGUCHI; J W SHELL
Journal:  J Pharm Sci       Date:  1963-02       Impact factor: 3.534

3.  Physicochemical properties of crystalline forms of ethynylestradiol solvates: comparison of thermal behavior with X-ray crystal structure.

Authors:  T Ishida; M Doi; M Shimamoto; N Minamino; K Nonaka; M Inoue
Journal:  J Pharm Sci       Date:  1989-04       Impact factor: 3.534

Review 4.  Pharmaceutical applications of polymorphism.

Authors:  J Haleblian; W McCrone
Journal:  J Pharm Sci       Date:  1969-08       Impact factor: 3.534

5.  Some physicochemical properties of glassy indomethacin.

Authors:  E Fukuoka; M Makita; S Yamamura
Journal:  Chem Pharm Bull (Tokyo)       Date:  1986-10       Impact factor: 1.645

6.  Solid-state nuclear magnetic resonance (NMR) spectra of pharmaceutical dosage forms.

Authors:  P J Saindon; N S Cauchon; P A Sutton; C J Chang; G E Peck; S R Byrn
Journal:  Pharm Res       Date:  1993-02       Impact factor: 4.200

Review 7.  Solid-state nuclear magnetic resonance spectroscopy: theory and pharmaceutical applications.

Authors:  D E Bugay
Journal:  Pharm Res       Date:  1993-03       Impact factor: 4.200

8.  Kinetic study of the polymorphic transformations of phenylbutazone.

Authors:  Y Matsuda; E Tatsumi; E Chiba; Y Miwa
Journal:  J Pharm Sci       Date:  1984-10       Impact factor: 3.534

9.  Fenoprofen: drug form selection and preformulation stability studies.

Authors:  C A Hirsch; R J Messenger; J L Brannon
Journal:  J Pharm Sci       Date:  1978-02       Impact factor: 3.534

10.  X-ray crystallographic characterization of two polymorphs of 8-(2-methoxycarbonylamino-6-methylbenzyloxy)-2-methyl-3-(2- propynyl)-imidazo [1,2-a]pyridine.

Authors:  A Miyamae; S Koda; S Kitamura; Y Okamoto; Y Morimoto
Journal:  J Pharm Sci       Date:  1990-03       Impact factor: 3.534

View more
  39 in total

1.  Quantitative correlation between initial dissolution rate and heat of solution of drug.

Authors:  K Terada; H Kitano; Y Yoshihashi; E Yonemochi
Journal:  Pharm Res       Date:  2000-08       Impact factor: 4.200

2.  What is the true solubility advantage for amorphous pharmaceuticals?

Authors:  B C Hancock; M Parks
Journal:  Pharm Res       Date:  2000-04       Impact factor: 4.200

Review 3.  Diamonds in the rough: protein crystals from a formulation perspective.

Authors:  A Jen; H P Merkle
Journal:  Pharm Res       Date:  2001-11       Impact factor: 4.200

4.  Investigation of solid-state reactions using variable temperature X-ray powder diffractometry. II. Aminophylline monohydrate.

Authors:  Suneel K Rastogi; Marek Zakrzewski; Raj Suryanarayanan
Journal:  Pharm Res       Date:  2002-09       Impact factor: 4.200

Review 5.  Differential scanning calorimetry techniques: applications in biology and nanoscience.

Authors:  Pooria Gill; Tahereh Tohidi Moghadam; Bijan Ranjbar
Journal:  J Biomol Tech       Date:  2010-12

6.  Investigation of the multi-step dehydration reaction of theophylline monohydrate using 2-dimensional powder X-ray diffractometry.

Authors:  Cletus Nunes; Arumugam Mahendrasingam; Raj Suryanarayanan
Journal:  Pharm Res       Date:  2006-09-01       Impact factor: 4.200

7.  The role of molecular structure in the crystal polymorphism of local anesthetic drugs: crystal polymorphism of local anesthetic drugs, part X.

Authors:  Andrea C Schmidt
Journal:  Pharm Res       Date:  2005-11-16       Impact factor: 4.200

8.  Quantification of crystallinity in substantially amorphous materials by synchrotron X-ray powder diffractometry.

Authors:  Cletus Nunes; Arumugam Mahendrasingam; Raj Suryanarayanan
Journal:  Pharm Res       Date:  2005-08-31       Impact factor: 4.200

9.  Influence of Hydroxypropyl Methylcellulose on Metronidazole Crystallinity in Spray-Congealed Polyethylene Glycol Microparticles and Its Impact with Various Additives on Metronidazole Release.

Authors:  Ching Mien Oh; Paul Wan Sia Heng; Lai Wah Chan
Journal:  AAPS PharmSciTech       Date:  2015-05-02       Impact factor: 3.246

10.  Particle size dependent molecular rearrangements during the dehydration of trehalose dihydrate in situ FT-Raman spectroscopy.

Authors:  L S Taylor; A C Williams; P York
Journal:  Pharm Res       Date:  1998-08       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.